Hypersensitivity Reactions to Taxanes and Subsequent Treatment with Nab- Paclitaxel: Case Reports of 2 Women with Early-Stage Breast Cancer
Treatment outcomes for nab-paclitaxel vs standard paclitaxel (5). | Download Table
Paclitaxel – Wikipedia
![PDF] Safety and Efficacy of nab-Paclitaxel in the Treatment of Patients with Breast Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2b8243d0cd6da82dad4e6b60a9fd68978010e599/10-Table5-1.png "PDF] Safety and Efficacy of nab-Paclitaxel in the Treatment of Patients with Breast Cancer | Semantic Scholar")
PDF] Safety and Efficacy of nab-Paclitaxel in the Treatment of Patients with Breast Cancer | Semantic Scholar
Randomized phase II study of nab‐paclitaxel as first‐line chemotherapy in patients with HER2‐negative metastatic breast cancer - Tamura - 2017 - Cancer Science - Wiley Online Library
NEJM on X: "#VisualAbstract: Aezolizumab + nab-paclitaxel as first-line therapy for patients with advanced or metastatic triple-negative #breastcancer significantly prolonged progression-free survival, particularly among those with PD-L1–positive ...
Counteracting gemcitabine+nab-paclitaxel induced dysbiosis in KRAS wild type and KRASG12D mutated pancreatic cancer in vivo model | Cell Death Discovery
Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic b | CEOR
Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial - The Lancet Gastroenterology & Hepatology
nab-paclitaxel, paclitaxel, and docetaxel in metastatic breast cancer:... | Download Table
Pharmacokinetics of Total and Unbound Paclitaxel After Administration of Paclitaxel Micellar or Nab-Paclitaxel: An Open, Randomized, Cross-Over, Explorative Study in Breast Cancer Patients | Advances in Therapy
Paclitaxel vs Abraxane (albumin-bound paclitaxel) | Leaders in Pharmaceutical Business Intelligence (LPBI) Group
nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial - Annals of Oncology
Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy—the P-SELECT trial (WJOG10617G)—a randomised phase II ...
Biomedicines | Free Full-Text | Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers—Improvements in Clinical Efficacy and Safety
Nanoparticle albumin-bound (nab)-paclitaxel for the treatment of pancr | GICTT
Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer? | Journal of Clinical Oncology
Chemical structure of Paclitaxel and the albumin conjugated variant... | Download Scientific Diagram
Nanoparticle Albumin-Bound Paclitaxel (Abraxane®) | SpringerLink
Nab-paclitaxel for the treatment of triple-negative breast cancer: Rationale, clinical data and future perspectives - ScienceDirect
Drug Delivery Systems for Cancer Therapeutics
Creating an Effective Nab Paclitaxel Drug Delivery System
Differences between solvent-based paclitaxel and nab- paclitaxel | Download Table
Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis | BMC Cancer | Full Text
